ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

JMAT Johnson Matthey Plc

1,753.00
-16.00 (-0.90%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Johnson Matthey Plc LSE:JMAT London Ordinary Share GB00BZ4BQC70 ORD 110 49/53P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -16.00 -0.90% 1,753.00 1,759.00 1,762.00 1,787.00 1,751.00 1,787.00 497,962 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 14.97B 276M 1.5064 11.69 3.23B

Johnson Matthey PLC Capital Markets Day Statement (3636R)

21/09/2017 7:01am

UK Regulatory


Johnson Matthey (LSE:JMAT)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Johnson Matthey Charts.

TIDMJMAT

RNS Number : 3636R

Johnson Matthey PLC

21 September 2017

Johnson Matthey Capital Markets Day Statement

Today, Johnson Matthey will hold a capital markets day in which it will outline its strategy for growth and value creation, at a group level and across its sectors. This growth is underpinned by its leading positions in high margin, technology driven growth markets. The company expects to deliver sustained growth in Clean Air, break out growth in Battery Materials and Health, and above market growth in Efficient Natural Resources. In the medium term, this will generate attractive returns:

   --      Expanding group ROIC to 20% 
   --      Delivering mid to high single digit EPS CAGR 
   --      And continuing a progressive dividend policy 

Overall our Clean Air business will deliver growth in the next ten years. It is expected to achieve strong single digit sales growth in the next two to three years from share gains already achieved in Europe light duty and from upcoming tighter legislation. In subsequent years, sales growth is expected to moderate as expansion in Asia, together with maintaining JM's strong position in heavy duty in North America, is partially offset by the move away from light duty diesel engines in Europe and by the increasing penetration globally of battery electric light duty vehicles.

The strategy for Efficient Natural Resources outlines how JM's technology leadership in the sector can deliver above market sales growth and improving operating margins from a focus on efficiency.

The programme of increased investment in the Health sector, which began in 2014, continues to build a deeper, broader pipeline of new products based on JM's expertise in active pharmaceutical ingredients. Building scale in this way will drive double digit sales growth and substantial margin expansion in this attractive sector beginning in 2019/20.

In New Markets, JM is focused on battery material technology and has plans to make an initial investment of up to GBP200 million, starting in 2018, to build capacity to drive growth in a market which could be more than $30 billion sales when battery electric vehicle penetration increases to around 10%.

Guidance is confirmed for the year ending 31st March 2018 and at constant currency with sales growth expected to be c6% with improving operating performance offset by non-cash items. Guidance on foreign exchange is unchanged; it is expected to benefit operating profit by GBP13 million with estimated restructuring benefits in this financial year unchanged at GBP10 million.

The group presentation will describe a further GBP50 million of savings, mainly from procurement, over the three years beginning in financial year 2018/19. Most of the savings will be reinvested with the balance for margin expansion. This is in addition to the GBP25 million of cost savings announced in June 2017.

Commenting on the capital markets day, Robert MacLeod, Chief Executive, said:

'Johnson Matthey has strong market leading businesses capable of sustained growth and value creation over the short, medium and long term.

'We will enhance our leadership in the high margin, technology driven growth markets we operate in through focused investment and efficiency throughout the group. We are world class chemists. We have the expertise to solve our customers' complex and increasingly challenging problems by scaling up fundamental chemistry to provide commercial solutions which drive our growth.

'This will create value and a cleaner and healthier world. Through the strategy we will describe at our capital markets day today, we aim to be one of the best performing, most trusted and admired specialty chemical companies in the world.'

Ends

Enquiries:

 
 Investor Relations           Head of Investor Relations      020 7269 8235 
  Simon McGough                Head of Investor Relations      020 7269 8426 
  Sarah Armstrong              Investor Relations Analyst      020 7269 8444 
  Katharine Burrow 
                              Director of Corporate 
  Media                        Communications                 020 7269 8407 
   Sally Jones                 Tulchan Communications          020 7353 4200 
   David Allchurch/Latika 
    Shah 
 www.matthey.com 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCPGURABUPMPUU

(END) Dow Jones Newswires

September 21, 2017 02:01 ET (06:01 GMT)

1 Year Johnson Matthey Chart

1 Year Johnson Matthey Chart

1 Month Johnson Matthey Chart

1 Month Johnson Matthey Chart

Your Recent History

Delayed Upgrade Clock